Clinical trialNCT02678455CompletedPhase 2Interventional

Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, Bangladesh

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment192Dengue

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the safety and immunogenicity of the recombinant live attenuated tetravalent dengue virus vaccine admixture TV005 (TetraVax-DV T005) in healthy adults, adolescents, and children in Dhaka, Bangladesh.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Beth D. Kirkpatrick, MD
Vaccine Testing Center, University of Vermont College of Medicine
Study ChairKOL profile →
clinicaltrials.gov ↗
Rashidul Haque, MD
Centre for Vaccine Sciences, International Centre for Diarrhoeal Disease Research, Bangladesh
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Bangladesh

International Centre for Diarrhoeal Disease Research, Bangladesh
Mīrpur, Dhaka Division, Bangladesh

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PlaceboTV005 vaccine

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Mar 2016
Primary completion: 10 Aug 2017
Completion: 5 Feb 2020
Last update posted: 17 Jan 2025
Registered enrollment: 192
Registry id: NCT02678455

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.